These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1273 related articles for article (PubMed ID: 23253237)

  • 21. The HLA-DRB1 shared epitope alleles differ in the interaction with smoking and predisposition to antibodies to cyclic citrullinated peptide.
    van der Helm-van Mil AH; Verpoort KN; le Cessie S; Huizinga TW; de Vries RR; Toes RE
    Arthritis Rheum; 2007 Feb; 56(2):425-32. PubMed ID: 17265477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis].
    Us D; Gülmez D; Hasçelik G
    Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
    Greiner A; Plischke H; Kellner H; Gruber R
    Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.
    Okada Y; Yamada R; Suzuki A; Kochi Y; Shimane K; Myouzen K; Kubo M; Nakamura Y; Yamamoto K
    Arthritis Rheum; 2009 Dec; 60(12):3582-90. PubMed ID: 19950296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A large-scale association study identified multiple HLA-DRB1 alleles associated with ACPA-negative rheumatoid arthritis in Japanese subjects.
    Terao C; Ohmura K; Kochi Y; Ikari K; Maruya E; Katayama M; Shimada K; Murasawa A; Honjo S; Takasugi K; Matsuo K; Tajima K; Suzuki A; Yamamoto K; Momohara S; Yamanaka H; Yamada R; Saji H; Matsuda F; Mimori T
    Ann Rheum Dis; 2011 Dec; 70(12):2134-9. PubMed ID: 21873689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA-DRB1 and anti-cyclic citrullinated peptide antibody production in rheumatoid arthritis.
    Senkpiehl I; Marget M; Wedler M; Jenisch S; Georgi J; Kabelitz D; Steinmann J
    Int Arch Allergy Immunol; 2005 Aug; 137(4):315-8. PubMed ID: 15970640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection against anti-citrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA-DRB1*1301: a meta-analysis of HLA-DRB1 associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in four European populations.
    van der Woude D; Lie BA; Lundström E; Balsa A; Feitsma AL; Houwing-Duistermaat JJ; Verduijn W; Nordang GB; Alfredsson L; Klareskog L; Pascual-Salcedo D; Gonzalez-Gay MA; Lopez-Nevot MA; Valero F; Roep BO; Huizinga TW; Kvien TK; Martín J; Padyukov L; de Vries RR; Toes RE
    Arthritis Rheum; 2010 May; 62(5):1236-45. PubMed ID: 20131291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis.
    van der Helm-van Mil AH; Verpoort KN; Breedveld FC; Huizinga TW; Toes RE; de Vries RR
    Arthritis Rheum; 2006 Apr; 54(4):1117-21. PubMed ID: 16572446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new classification of HLA-DRB1 alleles differentiates predisposing and protective alleles for autoantibody production in rheumatoid arthritis.
    Gourraud PA; Dieudé P; Boyer JF; Nogueira L; Cambon-Thomsen A; Mazières B; Cornélis F; Serre G; Cantagrel A; Constantin A
    Arthritis Res Ther; 2007; 9(2):R27. PubMed ID: 17328818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of human leucocyte antigen-DRB1 on the susceptibility to rheumatoid arthritis and on the production of anti-cyclic citrullinated peptide antibodies in a Portuguese population.
    Ligeiro D; Fonseca JE; Abade O; Abreu I; Cruz M; Nero P; Cavaleiro J; Teles J; Trindade H; Caetano JM; Branco J
    Ann Rheum Dis; 2007 Feb; 66(2):246-8. PubMed ID: 16793843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA-DRB1*0404 is strongly associated with high titers of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis.
    Charpin C; Balandraud N; Guis S; Roudier C; Toussirot E; Rak J; Lambert N; Martin M; Reviron D; Roudier J; Auger I
    Clin Exp Rheumatol; 2008; 26(4):627-31. PubMed ID: 18799094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.
    van Gaalen FA; van Aken J; Huizinga TW; Schreuder GM; Breedveld FC; Zanelli E; van Venrooij WJ; Verweij CL; Toes RE; de Vries RR
    Arthritis Rheum; 2004 Jul; 50(7):2113-21. PubMed ID: 15248208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Very high levels of anti-citrullinated protein antibodies are associated with HLA-DRB1*15 non-shared epitope allele in patients with rheumatoid arthritis.
    Laki J; Lundström E; Snir O; Rönnelid J; Ganji I; Catrina AI; Bengtsson C; Saevarsdottir S; Wick MC; Alfredsson L; Klareskog L; Padyukov L
    Arthritis Rheum; 2012 Jul; 64(7):2078-84. PubMed ID: 22307773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients.
    Snir O; Widhe M; Hermansson M; von Spee C; Lindberg J; Hensen S; Lundberg K; Engström A; Venables PJ; Toes RE; Holmdahl R; Klareskog L; Malmström V
    Arthritis Rheum; 2010 Jan; 62(1):44-52. PubMed ID: 20039432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opposing effects of HLA-DRB1*13 alleles on the risk of developing anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis.
    Lundström E; Källberg H; Smolnikova M; Ding B; Rönnelid J; Alfredsson L; Klareskog L; Padyukov L
    Arthritis Rheum; 2009 Apr; 60(4):924-30. PubMed ID: 19333936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
    Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
    J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
    Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
    J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis.
    Alexiou I; Germenis A; Ziogas A; Theodoridou K; Sakkas LI
    BMC Musculoskelet Disord; 2007 Apr; 8():37. PubMed ID: 17448247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: relation with clinical features, cytokines and HLA-DRB1].
    Correa PA; Tobón GJ; Citera G; Cadena J; Schneeberger E; Camargo JF; Maldonado-Cocco JA; Anaya JM
    Biomedica; 2004 Jun; 24(2):140-52. PubMed ID: 15495594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of anti-cyclic citrullinated peptide antibody levels with PADI4 haplotypes in early rheumatoid arthritis and with shared epitope alleles in very late rheumatoid arthritis.
    Cha S; Choi CB; Han TU; Kang CP; Kang C; Bae SC
    Arthritis Rheum; 2007 May; 56(5):1454-63. PubMed ID: 17469103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 64.